Development of a microbiome relevant image-capture food analysis tool.

Phyla’s vision is to be the world’s first integrated solution for gut health through a digital health platform for those affected by Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS). Phyla’s platform combines an at-home gut microbiome (intestinal bacteria) stool testing subscription and a mobile application for self-reported disease and lifestyle parameter tracking.
It is well known that nutrition and the microbiome have a large impact on disease activity and patient wellbeing in IBS and IBD. Through therapeutic approaches and nutrition changes, patients are able to reduce disease activity and improve their quality of life. Research continues to show that our diets do not only feed our own bodies but also our gut microbiome, the trillions of bacteria in our intestine. With the microbiome’s heavy implication in disease activity in IBD and IBS, it is therefore important to understand at a more granular level what exactly is being fed to the bacteria in our gut. Phyla aims to develop machine learning models that analyze a user’s microbiome and lifestyle data in order to provide personalized nutrition and lifestyle recommendations to help with disease management.

Faculty Supervisor:

Ioannis Mitliagkas

Student:

Partner:

Phyla

Discipline:

Computer science

Sector:

Health and Related Sciences & Technology

University:

Université de Montréal

Program: